Search research articles
Contact Us
Filters
Showing results (151-160 of 333) with videos related to
Page
of 34
Sort By:
European Journal of Internal Medicine
|
September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis
Christian Labenz, Michael Nagel, Gerrit Toenges, et al.
Hepatology Communications
|
October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosis
Simon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
Journal of Hepatology
|
May 1, 2020
Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum
Oliver Glass, Claudia Filozof, Mazen Noureddin, et al.
Zeitschrift Fur Gastroenterologie
|
June 17, 2015
[First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology]
J Weiss, M Rau, H Bantel, et al.
Scientific Reports
|
September 9, 2021
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
Anja Baumann, Anika Nier, Angélica Hernández-Arriaga, et al.
Scientific Reports
|
October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
Maurice Michel, Cornelius Hess, Leonard Kaps, et al.
Journal of Hepatology
|
March 31, 2023
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials
Raluca Pais, Bertrand Cariou, Mazen Noureddin, et al.
Gut
|
July 30, 2025
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort
Vlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi, et al.
Journal of Clinical Medicine
|
August 12, 2022
Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4
Katharina John, Martin Franck, Sherin Al Aoua, et al.
Gastroenterologia Y Hepatologia
|
October 27, 2023
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study
Anum Shaikh, Gabriel Pedra, Leonardo Ruiz-Casas, et al.
Page
of 34
Search research articles
Search
Showing results (151-160 of 333) with videos related to
Sort By:
Page
of 34
European Journal of Internal Medicine
|
September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis
Christian Labenz, Michael Nagel, Gerrit Toenges, et al.
Hepatology Communications
|
October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosis
Simon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
Journal of Hepatology
|
May 1, 2020
Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum
Oliver Glass, Claudia Filozof, Mazen Noureddin, et al.
Zeitschrift Fur Gastroenterologie
|
June 17, 2015
[First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology]
J Weiss, M Rau, H Bantel, et al.
Scientific Reports
|
September 9, 2021
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
Anja Baumann, Anika Nier, Angélica Hernández-Arriaga, et al.
Scientific Reports
|
October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
Maurice Michel, Cornelius Hess, Leonard Kaps, et al.
Journal of Hepatology
|
March 31, 2023
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials
Raluca Pais, Bertrand Cariou, Mazen Noureddin, et al.
Gut
|
July 30, 2025
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort
Vlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi, et al.
Journal of Clinical Medicine
|
August 12, 2022
Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4
Katharina John, Martin Franck, Sherin Al Aoua, et al.
Gastroenterologia Y Hepatologia
|
October 27, 2023
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study
Anum Shaikh, Gabriel Pedra, Leonardo Ruiz-Casas, et al.
Page
of 34